Annual Conference 2015

Home / Annual Conference 2015

C-KIN 2015

The C-KIN 2015 conference was organised under the auspices of the European Organisation for Research and Treatment of Cancer (EORTC) and the International Society of Geriatric Oncology (SIOG), and endorsed by the International Society of Nephrology (ISN) and the European Renal Association-European Dialysis and Transplantation Association (ERA-EDTA).

C-KIN 2015 included joint sessions with the American Society of Clinical Oncology (ASCO), the European Association of Hospital Pharmacists (EAHP), EORTC and SIOG.

#box-icon-5c4729284722a p{color:#7f7f7f;}
.button-5c4729284b0a9 { margin-bottom: 15px; margin-top: 0px; min-width: 0px !important; } .button-5c4729284b0a9 { background-color:#38b49d; } .mk-button.button-5c4729284b0a9.flat-dimension:hover { background-color:#252525 !important; }

Cancer & the Kidney International Network’s First Annual Conference

14–15 April 2015
Brussels, Belgium

The Cancer & the Kidney International Network (C-KIN) selected the city of Brussels, Belgium, to host its first C-KIN Annual Conference, which took place on 14-15 April 2015 at the Crowne Plaza Hotel.

C-KIN is the first and only truly international network of healthcare professionals, clinicians and researchers, focusing on kidney-related issues in cancer patients.

The C-KIN Annual Conference aimed at gathering healthcare professionals, clinicians and researchers involved in the care of cancer patients to share recent research developments, education in this field and to offer networking opportunities in order to improve knowledge and cancer patient care.

Associated kidney disease is highly frequent in cancer patients, up to 25% in breast, colorectal, lung, or ovarian cancers, and nearly 40% in kidney cancer. Patients with cancer and Chronic Kidney Disease (CKD) present with higher mortality rates as compared to patients with normal renal function. Overall survival is significantly reduced, and cancer-specific mortality is increased. This is a key issue for the whole healthcare staff, and at the forefront oncologists and nephrologists, who should be aware of the specificities required for the care of these patients.

The importance of this topic is highlighted by the high-level endorsements this first C-KIN Annual Conference had with the support of EORTC, SIOG, ISN and the ERA-EDTA. Furthermore, joint sessions were organised with SIOG, EAHP and ASCO